Experience Matters
Providing expert advice in market access, health economics, pricing & reimbursement and regulatory affairs in Australia, New Zealand and the Asia Pacific region.
Welcome to Lucid Health Consulting, an IQVIA business: Your Gateway to Pharmaceutical and Medical Markets in Australia and the Asia-Pacific
With over 30 years of industry leadership, Lucid Health Consulting is the trusted partner for companies and associations in the pharmaceuticals, medical device, medical technology, and biotech sectors in Australia.
Our team of experts includes health economists, regulatory affairs specialists, reimbursement and HTA consultants, market and patient access advisors, and statisticians. We have a proven track record of enabling companies and organisations to optimise the entry of their pharmaceuticals, biotech products medical devices and technologies into the Australian market.
Whether you’re looking to overcome complex regulatory hurdles, answer critical business questions, streamline your market entry process or require product sponsorship in Australia, we are here to help.
Let us help you unlock new opportunities and drive success across Australia and the Asia-Pacific region.
How we can help your business?
What’s New
Read our articles, find out about our upcoming webinars and speaking engagements for the latest industry insights.
8th Annual Drugs & Devices Australia Webinar – Reimbursement Update 2022
Free Webinar: 8th Annual Drugs & Devices Australia – Reimbursement Update Please join us for this free webinar, hosted by George Papadopoulos, Partner & Director of Lucid Health Consulting and Sarah Griffin, Director of MedTechnique Consulting as they discuss...
Welcome Kathryn Williams Day to the Lucid Health Consulting team
We are thrilled to announce the addition of Kathryn Williams Day to the Lucid Health Consulting team as Senior Consultant, Regulatory Affairs. Katy brings extensive regulatory affairs experience, backed by training in clinical pharmacy and public health in both the...
Lucid Health Consulting joint publication – Journal of Medical Economics.
Read our Director George Papadopoulos’s recently published joint manuscript, in the Journal of Medical Economics; Cost-effectiveness analysis of arthroscopic injection of a bioadhesive hydrogel implant in conjunction with microfracture for the treatment of focal...
What our clients are saying.
An IQVIA Business
Contact Us
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations. Learn more at www.iqvia.com
ADDRESS
Level 8,141 Walker Street, North Sydney, NSW, 2060
PHONE
GET IN TOUCH
Privacy Policy
Your Privacy Choices












